Candela's GentleYAG laser receives FDA 510k clearance for the treatment of Pseudofolliculitis barbae
Candela Corporation announced that its GentleYAG Nd:YAG long pulse hair and vascular lesion laser has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) for the ...
WAYLAND, Mass.--(BUSINESS WIRE)--March 18, 2005--Candela Corporation (NASDAQ: CLZR) announced today that it has received approval from the Japanese Ministry of Health to sell its GentleYAG(R) laser ...
Candela Corp. of Wayland announced today that the U.S. Food and Drug Administration received market clearance its GentleYAG laser device to be used for benign pigmented lesions such as age spots, skin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results